drug · Product Intelligence

Everolimus
Pipeline Intelligence

Everolimus: 3 indexed trials, 3 sponsors; 0 linked Orange Book patents and 6 FDA-linked events where matched.

⚗

3Indexed trials

▦

3Sponsors

⌁

0Orange Book patent links

◎

6FDA-linked events

NCT01070316Children's Hospital Medical Center, Cincinnati · epilepsyPHASE1, PHASE2

NCT01997255Baylor College of Medicine · epilepsyPHASE2

NCT02069093Novartis Pharmaceuticals · out_of_scopePHASE2

Orange Book match found; no listed patent relation was retained for this product match.

FDA_APPROVALEVEROLIMUS · 2026-05-12

FDA_APPROVALEVEROLIMUS · 2025-04-09

FDA_APPROVALEVEROLIMUS · 2020-06-08

FDA_APPROVALEVEROLIMUS · 2019-12-09

FDA_APPROVALEVEROLIMUS · 2019-04-19

FDA_APPROVALZORTRESS · 2018-08-10

FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.

EverolimusPipeline Intelligence